Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (2)
Nature Communications (1)
Nature Reviews Cancer (1)
Nature Structural & Molecular Biology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (3)
Amendments and Corrections (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Diseases
Drug discovery
Health care
Molecular biology
Oncology
Physiology
Structural biology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–5 of 5 results

Advanced filters: Author: D Resetca Clear advanced filters

Multiple direct interactions of TBP with the MYC oncoprotein

Structural, biophysical and modeling approaches, combined with cell-based assays, reveal how the oncogenic transcription factor MYC interacts with subunits of the general transcription factor TFIID to modulate gene expression.

Yong Wei
Diana Resetca
Maria Sunnerhagen
Research04 Nov 2019
Nature Structural & Molecular Biology

Volume: 26, P: 1035-1043
MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability

Deregulated MYC activity is oncogenic and is deregulated in a large fraction of human cancers. Here the authors find that protein phosphatase 1 and its regulatory subunit PNUTS controls MYC stability and its interaction with chromatin.

Dharmendra Dingar
William B. Tu
Linda Z. Penn
ResearchOpen Access29 Aug 2018
Nature Communications

Volume: 9, P: 1-13
Erratum: Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

A M Eiring
B D G Page
M W Deininger
Amendments and Corrections03 May 2017
Leukemia

Volume: 31, P: 1253-1254
The interplay between cell signalling and the mevalonate pathway in cancer

The mevalonate (MVA) pathway is an essential metabolic pathway that is affected by many oncogenic signalling pathways. This Review discusses the opportunity to immediately target the MVA pathway in cancer with agents approved for other therapeutic uses, such as statins.

Peter J. Mullen
Rosemary Yu
Linda Z. Penn
Reviews26 Aug 2016
Nature Reviews Cancer

Volume: 16, P: 718-731
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

A M Eiring
B D G Page
M W Deininger
Research19 Aug 2014
Leukemia

Volume: 29, P: 586-597